+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review



Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review



Infection 42(5): 801-809



We report three cases of external ventricular derivation infections caused by multidrug-resistant Gram-negative rods and treated successfully with intraventricular colistin. The intrathecal or intraventricular use of colistin have been reported in more than 100 cases without any consensus on dosage, duration and type (monotherapy or combination therapy) of treatment. Based on our comprehensive review of the relevant literature relating to both clinical and pharmacokinetic data, we conclude that the intrathecal/intraventricular administration of colistin is a safe and effective option to treat central nervous system infections caused by multidrug-resistant Gram-negative bacteria.

(PDF emailed within 0-6 h: $19.90)

Accession: 053949572

Download citation: RISBibTeXText

PMID: 24728736

DOI: 10.1007/s15010-014-0618-0


Related references

Intraventricular or intrathecal colistin for the treatment of central nervous system infections caused by multidrug-resistant Gram-negative bacteria. Expert Review of Anti-Infective Therapy 12(4): 471-478, 2015

Negative Pressure Wound Treatment of Infections Caused By Extensively Drug-Resistant Gram-Negative Bacteria After Liver Transplantation: Two Case Reports. Transplantation Proceedings 47(7): 2145-2149, 2016

Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review. Journal of ChemoTherapy 29(Sup1): 2-9, 2018

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial. Lancet. Infectious Diseases 18(4): 391-400, 2018

Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study, the patient, the bug or the drug?. Journal of Infection 66(5): 401-414, 2014

Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. International Journal of Antimicrobial Agents 25(1): 11-25, 2004

Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review. International Journal of Antimicrobial Agents 41(6): 499-508, 2013

New antibacterial agents for treating infections caused by multi-drug resistant Gram-negative bacteria. Expert Opinion on Investigational Drugs 17(3): 297-302, 2008

Multi-Drug-Resistant Gram-Negative Infections in Deployment-Related Trauma Patients. Surgical Infections 18(3): 357-367, 2017

Use of colistin in the treatment of multiple-drug-resistant gram-negative infections. American Journal of Health-System Pharmacy 62(1): 39-47, 2005

Is colistin effective in the treatment of infections caused by multidrug-resistant (MDR) or extremely drug-resistant (XDR) gram-negative microorganisms in children?. Diagnostic Microbiology and Infectious Disease 85(2): 233-238, 2017

Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria. Journal of Infection 56(3): 185-190, 2008

Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria. Journal of Clinical Pharmacy and Therapeutics 39(3): 272-276, 2015

Specific Clinical Profile and Risk Factors for Mortality in General Surgery Patients with Infections by Multi-Drug-Resistant Gram-Negative Bacteria. Surgical Infections 18(5): 625-633, 2017

Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: a retrospective study. Bmc Anesthesiology 13(1): 45, 2013